UW Health's Dr. Jeff Pothof discusses the FDA's authorization of the first artificial intelligence platform for breast cancer ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

FDA approves CLAIRITY BREAST, a new AI breast cancer prediction tool that helps doctors assess five-year risk from routine ...

A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

More and more devices using AI and machine learning technology are becoming available for purchase, something that’s just as ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

The FDA announced last week it launched Elsa, an AI tool designed to help employees work better. AI also is impacting ...

JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical ...

Learn key considerations for data selection for AI-driven MedTech development and how to identify the ideal data sets.

Artificial intelligence (AI) already helps clinicians to make diagnoses, triage critical cases and transcribe clinical notes ...